We further confirmed the impact of CdGAP on human prostate cancer cell migration and invasion by ectopic expression of CdGAP in DU-145 and 22Rv1 cells and in the androgen-sensitive LNCaP cell line (Supplementary Fig. 3c). This evidence concerns the gene ARHGAP31 and prostate cancer.